These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7372246)

  • 21. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
    Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
    Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basis of statistical methodology in medicine. II. Basic methodical requirements].
    Holcík J; Gerylovová A
    Vnitr Lek; 1974 Apr; 20(4):380-4. PubMed ID: 4827331
    [No Abstract]   [Full Text] [Related]  

  • 23. [Considerations on disability evaluation in myocardial infarct].
    Mine T
    Med Leg Dommage Corpor; 1971; 4(2):113-4. PubMed ID: 5109553
    [No Abstract]   [Full Text] [Related]  

  • 24. [2 platelet inhibitors administered at the same time. Improved prognosis in myocardial infarct?]].
    MMW Fortschr Med; 2001 Jan; 143(1-2):54. PubMed ID: 11219401
    [No Abstract]   [Full Text] [Related]  

  • 25. [CARDIAC INFARCTS IN MANUAL WORKERS AND YOUNG ADULTS--PROBLEM AND WARNING].
    MENSEN H
    Hippokrates; 1964 Oct; 35():749-58. PubMed ID: 14325438
    [No Abstract]   [Full Text] [Related]  

  • 26. [So-called "negative list" and its consequences for pharmacotherapy by dentists].
    Estler CJ
    Dtsch Zahnarztl Z; 1983 Jul; 38(7):663-4. PubMed ID: 6578009
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Dotzer F; Gromer H
    Fortschr Med; 1993 May; 111(14):245-8. PubMed ID: 8335304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombolytic therapy in acute myocardial infarct. The facts and the statistical ideal].
    Baruzzi AC; Knobel E; Cirenza C; Fehér J
    Arq Bras Cardiol; 1994 Aug; 63(2):87-9. PubMed ID: 7661716
    [No Abstract]   [Full Text] [Related]  

  • 29. [European legislation on the development of biological similarity: recommendations on the European Agency on Medications with regard to efficacy and safety].
    London G
    Nephrol Ther; 2009 Feb; 5 Spec No1():6-9. PubMed ID: 19233076
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect and effectiveness].
    Begemann H
    Med Klin; 1981 Aug; 76(18):483. PubMed ID: 7278788
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidemiology and prognosis of myocardial infarct and chronic heart failure].
    Ertl G; Gaudron P; Eilles C; Kochsiek K
    Herz; 1993 Dec; 18 Suppl 1():406-15. PubMed ID: 8125420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Are children in the shadow region of drug therapy].
    Hämäläinen M
    Duodecim; 2001; 117(18):1781-2. PubMed ID: 12181973
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
    Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of thrombolytic treatment on the prognosis of myocardial infarct in females].
    Bosch X; López A
    Rev Esp Cardiol; 1994; 47 Suppl 3():32-9. PubMed ID: 7816978
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term prognosis for patients undergoing thrombolysis during the acute phase of myocardial infarction].
    Bosset AJ; Vogt P; Eeckhout E; van Melle G; Monnier P; Schaller MD; Stauffer JC; Kappenberger L; Goy JJ
    Ann Cardiol Angeiol (Paris); 1997; 46(5-6):303-10. PubMed ID: 9295890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of magnesium in acute myocardial infarct].
    Beuckelmann DJ
    Z Kardiol; 1996; 85 Suppl 6():129-34. PubMed ID: 9064957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute myocardial infarct. Better prognosis through potassium and magnesium?].
    MMW Fortschr Med; 2003 Oct; 145(40):53. PubMed ID: 14603607
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
    Kelle S; Roes SD; Klein C; Kokocinski T; de Roos A; Fleck E; Bax JJ; Nagel E
    J Am Coll Cardiol; 2009 Nov; 54(19):1770-7. PubMed ID: 19874990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MYOCARDIAL INFARCT IN THE ACUTE PHASE].
    GRAS A; MOUTAFFIAN JJ; GIRAUD M; JOUVE A
    Mars Med; 1964; 101():885-92. PubMed ID: 14247903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.